Respiratory suppliers are strongly encouraged to share comments with CMS on how the proposed NCD on noninvasive positive pressure ventilation (NIPPV) will negatively impact patients.

The DME market is expected to grow in the foreseeable future. An aging population will drive this growth.

Medtrade exhibitor Resmed has launched NightOwl™, a new home sleep apnea test.

What are the chances that competitive bidding could come back in 2025?

Walgreens has entered into an agreement to be acquired by a private equity firm in a $23.7 billion deal.

New meta-analysis demonstrates that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA).